Learn more about an IV P2Y12 platelet inhibitor specifically designed as an adjunct to PCI
Learn more about a next-generation hyaluronic acid that provides long-lasting relief for your patients with osteoarthritis knee pain.
Learn more about a first-in-class CD38-targeted monoclonal antibody approved for multiple myeloma patients at first relapse
Learn more about a once-daily treatment for partial-onset seizures that can be prescribed as monotherapy or adjunctive therapy.
Discover more about a diabetes treatment option with A1C reduction and additional benefits.